Simulations Plus Extends Research Collaborations with FDA and NIEHS

Reuters
Feb 10
<a href="https://laohu8.com/S/SLP">Simulations Plus</a> Extends Research Collaborations with FDA and NIEHS

Simulations Plus Inc. has announced the extension of two research collaborations with the U.S. Food and Drug Administration (FDA) and the National Institute of Environmental Health Sciences (NIEHS). These extended projects aim to advance research into computational and AI-powered new approach methodologies (NAMs) for food and chemical safety assessment. The collaboration with NIEHS focuses on modernizing chemical safety assessment through AI-driven tools, while both partnerships support ongoing federal efforts to develop and validate non-animal based, data-driven methods for regulatory safety evaluations. Simulations Plus will continue to provide its expertise and software engines to support these federal research initiatives.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simulations Plus Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260209178106) on February 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10